Delivery Order SPE2DB20D1109-SPE2DB25FP27M
- Not listed
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of QUILLIVANT XR 25 MG/5 ML SUSP 150ML medication. The $1,882.64 firm fixed price contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of May 27, 2025. Amerisourcebergen, a for-profit organization headquartered in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,505.64 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,186.56 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a specialty medication. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order worth $1,960.46 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a specialty medication, with a period of performance through October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,543.32 delivery order contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a 120 ml medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,577.04 delivery order contract is for the supply of Quillivant XR, a 25 mg/5 ml suspension medication, with an ultimate completion date of May 7, 2025. The contract is designated as a firm fixed-price Delivery Order, without any set-aside requirements. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $1,577.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Quillivant XR, a 25 mg/5 ml suspension medication. The contract is a firm fixed-price arrangement with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.95 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a specialty medication. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,712.24, is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,524.36, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP27MDelivery Order
This federal contract award is a delivery order valued at $1,557.72 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a pharmaceutical product, with a performance period through June 24, 2025. The contract is a firm-fixed price arrangement and is not a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/23/25 |